Effects of Medical Comorbidity on Anxiety Treatment Outcomes in Primary Care
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the effects of medical comorbidity on anxiety treatment outcomes. METHODS: Data were analyzed from 1004 primary care patients enrolled in a trial of a collaborative care intervention for anxiety. Linear-mixed models accounting for baseline characteristics were used to evaluate the effects of overall medical comorbidity (two or more chronic medical conditions [CMCs] versus fewer than two CMCs) and specific CMCs (migraine, asthma, and gastrointestinal disease) on anxiety treatment outcomes at 6, 12, and 18 months. RESULTS: At baseline, patients with two or more CMCs (n = 582; 58.0%) reported more severe anxiety symptoms (10.5 [95% confidence interval {CI} = 10.1-10.9] versus 9.5 [95% CI = 9.0-10.0], p = .003) and anxiety-related disability (17.6 [95% CI = 17.0-18.2] versus 16.0 [95% CI = 15.3-16.7], p = .001). However, their clinical improvement was comparable to that of patients with one or zero CMCs (predicted change in anxiety symptoms = -3.9 versus -4.1 at 6 months, -4.6 versus -4.4 at 12 months, -4.9 versus -5.0 at 18 months; predicted change in anxiety-related disability = -6.4 versus -6.9 at 6 months, -6.9 versus -7.3 at 12 months, -7.3 versus -7.5 at 18 months). The only specific CMC with a detrimental effect was migraine, which was associated with less improvement in anxiety symptoms at 18 months (predicted change = -4.1 versus -5.3). CONCLUSIONS: Effectiveness of the anxiety intervention was not significantly affected by the presence of multiple CMCs; however, patients with migraine displayed less improvement at long-term follow-up. Trial Registration ClinicalTrials.com Identifier: NCT00347269.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Katon, W., Lin, E. H. B., & Kroenke, K. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.11.005 · Cited by 965 · cited 1×
“, asthma (17), cardiovascular disease (18), diabetes (19)) and to increase risk for incidence or disease progression in others (e.”
BackgroundMcWilliams, L. A., Cox, B. J., & Enns, M. W. (2003) · Pain · doi:10.1016/s0304-3959(03)00301-4 · Cited by 951
Anxiety disorders and comorbid medical illness
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., Lydiard, R. B., Massie, M. J., Katon, W., Laden, S. K., et al. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.12.006 · Cited by 668
Self-citationRoy-Byrne, P., Craske, M. G., Sullivan, G., Rose, R. D., Edlund, M. J., Lang, A. J., Bystritsky, A., Welch, S. S., Chavira, D. A., Golinelli, D., et al. (2010) · JAMA · doi:10.1001/jama.2010.608 · Cited by 452
Self-citationSareen, J., Cox, B. J., Clara, I., & Asmundson, G. J. G. (2005) · Depression and Anxiety · doi:10.1002/da.20072 · Cited by 389
Comorbidity of Fibromyalgia and Psychiatric Disorders
Arnold, L. M., Hudson, J. I., Keck, P. E., Auchenbach, M. B., Javaras, K. N., & Hess, E. V. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0807 · Cited by 382 · cited 1×
“Increased prevalence of anxiety disorders is observed in patients with a diverse array of CMCs, including cardiovascular disease (1,2), gastrointestinal disease (1,5), respiratory disease (1,6,7), migraine (1,8), chronic pain (1,9,10), and cancer (11).”
BackgroundSareen, J., Jacobi, F., Cox, B. J., Belik, S.-L., Clara, I., & Stein, M. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2109 · Cited by 361 · cited 2×
“, irritable bowel syndrome (13,14), asthma (7)) and report lower levels of health-related quality of life (15,16).”
BackgroundSelf-citationPsychological treatment of chronic pain
Kerns, R. D., Sellinger, J., & Goodin, B. R. (2011) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-090310-120430 · Cited by 267 · cited 1×
“, acceptancebased techniques (40)) that may aid patients in coping with symptoms of medical illness and anxiety.”
BackgroundSmoller, J. W., Pollack, M. H., Wassertheil-Smoller, S., Jackson, R. D., Oberman, A., Wong, N. D., & Sheps, D. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1153 · Cited by 204
Cited by
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
“While medical comorbidity is associated with more severe anxiety symptoms and anxiety-related disability, the effectiveness of anxiety interventions is not significantly affected by the presence of multiple medical comorbidities, with the exception of migraine sufferers who display less improvement at long-term follow…”
BackgroundPateraki, E., & Morris, P. G. (2018) · Journal of Asthma · doi:10.1080/02770903.2017.1350967 · Cited by 37
Daniels, J., Parker, H., & Salkovskis, P. M. (2020) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2019.11.003 · Cited by 26
Treating Anxiety in the Presence of Medical Comorbidity: Calmly Moving Forward
Rollman, B. L., & Huffman, J. C. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000011 · Cited by 12
“They also advance our understanding of the potential benefits derived from treating anxiety by demonstrating that the CALM intervention was as effective among patients with two or more CMCs as in patients with one or no CMCs (3).”
Background
Metadata
- Authors
- Campbell-Sills, L., Stein, M. B., Sherbourne, C. D., Craske, M. G., Sullivan, G., Golinelli, D., Lang, A. J., Chavira, D. A., Bystritsky, A., Rose, R. D., Welch, S. S., Kallenberg, G. A., & Roy-Byrne, P.
- Venue
- Psychosomatic Medicine
- Published
- 2013-10
- Volume
- 75
- Issue
- 8
- Pages
- 713-720
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W1989869867
- Cited by
- 21
- References
- 16
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Medical Comorbidity on Anxiety Treatment Outcomes in Primary Care. https://app.cochat.ai/papers/10.1097/psy.0b013e31829def54
- The paper
- Campbell-Sills, L., Stein, M. B., Sherbourne, C. D., Craske, M. G., Sullivan, G., Golinelli, D., Lang, A. J., Chavira, D. A., Bystritsky, A., Rose, R. D., Welch, S. S., Kallenberg, G. A., & Roy-Byrne, P. (2013). Effects of Medical Comorbidity on Anxiety Treatment Outcomes in Primary Care. Psychosomatic Medicine. https://doi.org/10.1097/psy.0b013e31829def54
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.